Abstract:Chronic granulomatous disease (CGD) in children is a rare primary immunodeficiency disorder that can lead to life-threatening infections and inflammatory complications. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is increasingly being used to treat severe CGD in children. We conducted a multicenter retrospective analysis of children with CGD who were treated with allo-HSCT at four pediatric hematopoietic stem cell transplant centers in China from September 2005 to December 2019. The study included a total of 171 patients (169 males and 2 females). The median age at the time of transplantation was 6.1 (0-16.4) years. Among them, 154 patients had X-linked recessive inheritance caused by CYBB gene mutations, 12 patients were autosomal recessive, 1 patient had DNAH11 and HYDIN gene mutations, and 4 patients had no gene mutations. The median follow-up period was 36.3 (1.9-79) months. All participating patients were applied to myeloablative conditioning (MAC) regimens. The rates of OS, EFS, and GEFS within three years were 87.5%, 85.3%, and 75.2%, respectively. The total graft failure and the total mortality rate were 5.3% and 11.1%. The cumulative incidence of acute GVHD was 53.8% and the incidence of chronic GVHD was 12.9%, The incidence of chronic GVHD was higher for patients who received unrelated donor cord blood stem cell transplantation (UD-CB) (P = 0.001). Chronic GVHD and coinfections are the risk factors for OS and EFS in patients with CGD after receiving allo-HSCT. UD-CB is a risk factor for EFS and the presence of pneumonia before transplantation is a risk factor for OS. In conclusion, through this study, we have demonstrated that allo-HSCT has excellent efficacy in the treatment of CGD in children, especially, RD-haplo is associated with a lower rate of graft failure incidence and mortality than the treatment modalities of other donor type. Therefore, allo-HSCT is strongly recommended when a well-matched donor is available. If a well-matched donor is not available, the HLA-mismatched donor should be carefully evaluated, and the conditioning regimen modified accordingly.

Variant Type X91+ Chronic Granulomatous Disease: Clinical and Molecular Characterization in a Chinese Cohort

A Cohort of 169 Chronic Granulomatous Disease Patients Exposed to BCG Vaccination: a Retrospective Study from a Single Center in Shanghai, China (2004–2017)

Phenomic Analysis of Chronic Granulomatous Disease Reveals More Severe Integumentary Infections in X-Linked Compared With Autosomal Recessive Chronic Granulomatous Disease

Clinical and Molecular Features of Chronic Granulomatous Disease in Mainland China and a XL-CGD Female Infant Patient After Prenatal Diagnosis

Preimplantation genetic testing for X-linked chronic granulomatous disease induced by a CYBB gene variant: A case report

Genetic Characteristics, Infectious, and Noninfectious Manifestations of 32 Patients with Chronic Granulomatous Disease

Genetic and Clinical Profiles of Disseminated Bacillus Calmette-Guérin Disease and Chronic Granulomatous Disease in China

The Three CYBA Variants (rs4673, Rs1049254 and Rs1049255) Are Benign: New Evidence from a Patient with CGD.

Clinical and Genetic Characteristics of BCG Disease in Chinese Children: a Retrospective Study.

Molecular quality control machinery contributes to the leukocyte NADPH oxidase deficiency in chronic granulomatous disease.

Clinical Features of Chronic Granulomatous Disease: Analysis of 27 Cases

A Novel CD40LG Mutation Causing X‑linked Hyper-Igm Syndrome

Two distinct clinical progressions of P67phox-deficient CGD, both commencing with cervical lymphadenitis

Clinical Characteristics and Immunogenetics of Bcgosis/Bcgitis in Chinese Children: A 6 Year Follow-Up Study

Clinical presentation, diagnosis, and treatment of chronic granulomatous disease

Overlapping infection of Nocardia farcinica and Aspergillus fumigatus in a child with X-linked chronic granulomatous disease: a case report

Effect of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease in Children: A Multicentre, Retrospective Cohort Study in China.

Chronic granulomatous disease. Report on a national registry of 368 patients

Identification of Two Novel Mutations in Patients with X-Linked Primary Immunodeficiencies

First Report on Chronic Granulomatous Disease from Nepal and a Review of CYBC1 Deficiency

Genotype-Phenotype Correlations in Chronic Granulomatous Disease: Insights From a Large National Cohort